Guest guest Posted January 9, 2011 Report Share Posted January 9, 2011 WHO SHOULD BELL THE CAT ? The problems of misleading medicine promotion is common in all developing economies, only the degree of severity differs. No country is spared by the pharmaceutical industry in misleading the populations. While some countries have stringent laws and vigilant drug regulators, others have virtually no operational watchdog agency. The merry making pharma companies continue to deceit, cheat, mislead the populations in the countries where enforcement is lax. It is shame on the intelligence of the medical profession that such gimmickry continues unchecked. The medical profession looks the other way saying it has no role to play in this. Very few have come forward to even discuss this issue. Thanks dear moderator Dr Sanjay for shouldering the responsibility. The medical profession has one rare breed - medical activists, who are even though few in number but nevertheless highly potent and die hard, crazy, dedicated chasers. When nothing in the profession works, the medical activists do. NetRUM has many medical activists as members. We look forward to them to come up and shoulder the responsbility of waking up the responsible authorities from slumber to action in this area. Dr Vijay Thawani Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 9, 2011 Report Share Posted January 9, 2011 hello All, I believe there is a subtle difference between promotional literature and the patient information leaflet which is variously known as patient package inserts, patient information leaflets, information package inserts, prescribing information, and the drug product label. Promotional literature is, as the name suggests, meant for promotion which will always be in favour of the product.Promotional material has only ethical guidelines. All other material under the name of patient information leaflet is regulated by the FDA. So it is the prescriber who has to sift the chaff from wheat, and take information which is right. kunda From: Vijay <drvijaythawani@...>netrum Sent: Mon, 10 January, 2011 3:35:39 AMSubject: MEDICINE PROMOTION WHO SHOULD BELL THE CAT ? The problems of misleading medicine promotion is common in all developing economies, only the degree of severity differs. No country is spared by the pharmaceutical industry in misleading the populations. While some countries have stringent laws and vigilant drug regulators, others have virtually no operational watchdog agency. The merry making pharma companies continue to deceit, cheat, mislead the populations in the countries where enforcement is lax. It is shame on the intelligence of the medical profession that such gimmickry continues unchecked. The medical profession looks the other way saying it has no role to play in this. Very few have come forward to even discuss this issue. Thanks dear moderator Dr Sanjay for shouldering the responsibility. The medical profession has one rare breed - medical activists, who are even though few in number but nevertheless highly potent and die hard, crazy, dedicated chasers. When nothing in the profession works, the medical activists do. NetRUM has many medical activists as members. We look forward to them to come up and shoulder the responsbility of waking up the responsible authorities from slumber to action in this area. Dr Vijay Thawani Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 9, 2011 Report Share Posted January 9, 2011 Respected Sir,I had already posted what information should be provided (or is right) in the Promotional literature as per the WHO guidelines. The wrongs of Promotional Literature: It has been observed that the Pharmaceutical companies use various wrong strategies to promote drugs like : 1. They have been using emotional tools in their messages: Messages in promotional literature where there are attempts to persuade us by appealing to our emotions –our hopes, dreams or fears. 2. Appeal to the Celebrities- How can Celebrities who have no knowledge about the medicine information be used in the promotional literature to promote drugs. 3. Appeal to the Authority: A person may be chairman of some institute or the President of some institution but his words can not be used in the promotional literature as his words can not be completely relied and we should look for more reliable evidence whether the drug is really effective or advantageous. Plus the Authority may be influenced by the sponsor or the Pharmaceutical company. I will be providing examples of each of these in my next posts on netrum.On your query on the movie "Love and Other Drugs", I am extremely sorry, I am not able to answer that question as I have not watched that movie. May be at a later time, I may be able to answer to you about it. Regards Dr Sanjay Yallappa Choudhari JR2,Dept of Pharmacology GMC, NagpurFrom: Rollo Manning <rollom@...>Subject: Re: MEDICINE PROMOTIONnetrum Cc: "Ken Harvey" <k.harvey@...>Date: Monday, 10 January, 2011, 3:51 AM In looking at the rights and wrongs of current pharmaceutical medicine advertising I would like some explanation of how the film “Love and other drugs†is able to be shown in countries where direct to consumer advertising of prescription medicines is banned. I look forward to discussion and hopefully an explanation. Rollo ManningPharmacy and Public Relations ConsultantRWM ConsultancyPO Box 98 Parap NT 080408 8942 2101 or 0411 049 872Author of Blog Remote Living Aboriginals athttp://remoteaboriginals.blogspot.com/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.